◀ Back to PTGS2
MSH3 — PTGS2
Text-mined interactions from Literome
Barnett et al., Am J Physiol Gastrointest Liver Physiol 2000
(Gastritis) :
Basal acid secretion in both groups of rats was not affected by pretreatment with
DuP-697 , a selective
inhibitor of
cyclooxygenase-2
Caruso et al., Neuroendocrinology 2004
:
alpha-MSH and HS024 ( 1 nmol/rat ) alone
had no effect on iNOS and
COX-2 expression
Wang et al., FASEB J 2005
(MPTP Poisoning) :
MPP induced PGE2 increase was completely abolished by treatment with
DuP697 , a
COX-2 selective
inhibitor
Peng et al., Ann Hematol 2008
(Leukemia, Myelogenous, Chronic, BCR-ABL Positive) :
Dup-697 , a specific
COX-2 inhibitor , suppresses growth and induces apoptosis on K562 leukemia cells by cell-cycle arrest and caspase-8 activation
Kim et al., Anesth Analg 2012
(Disease Models, Animal...) :
The effects of intrathecally administered tianeptine and
DUP-697 ( a
cyclooxygenase-2 inhibitor ) were examined on flinching behavior evoked by intraplantar formalin injection, and their interaction was characterized using isobolographic analysis
Hay et al., Neuroreport 1997
(Hyperalgesia) :
However,
DuP 697
potentiated COX-2 mRNA induction, which indicates the existence of a potential regulatory mechanism to overcome COX-2 inhibition